Kobayashi Pharmaceutical Co., Ltd.
Research Kobayashi Pharmaceutical Co., Ltd. (4967.T) on Bullrun: market cap JPY 541.41B, P/E 333.2, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4967.T
- ExchangeTSE
- CountryJapan
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyJPY
- Market capJPY 541.41B
- P/E333.2
- Dividend yield1.5%
- Financial periodFY2025
- RevenueJPY 165.74B
- Revenue growth0.1%
- Net incomeJPY 3.66B
- Free cash flowJPY 11.58B
- Gross margin51.1%
Valuation Snapshot
latest market cap is JPY 541.41B; P/E is 333.2; dividend yield is 1.5%.
Peer valuation comparison
Latest P/E is 333.17x versus a Consumer Defensive sector median of 16.79x (1884.0% above).
Latest dividend yield is 1.45% versus a Consumer Defensive sector median of 2.92% (50.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 165.74B | JPY 3.66B | JPY 11.58B | 51.1% | 49.19 | JPY 62.31B | JPY 678.00M | JPY 211.00B |
| FY2024 | JPY 165.60B | JPY 10.07B | -JPY 15.38B | 52.9% | 135.42 | JPY 50.87B | JPY 846.00M | JPY 213.47B |
| FY2023 | JPY 173.46B | JPY 20.34B | JPY 4.79B | 55.6% | 268.16 | JPY 71.54B | JPY 987.00M | JPY 204.82B |
| FY2022 | JPY 166.26B | JPY 20.02B | JPY 15.69B | 55.5% | 259.59 | JPY 96.23B | JPY 792.00M | JPY 197.90B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 541.41B | 333.2 | 1.4% | 105 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 105 JPY, yield 1.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 104 JPY |
| FY2024 | 102 JPY |
| FY2023 | 101 JPY |
| FY2022 | 90 JPY |
| FY2021 | 83 JPY |
About Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Kobayashi Pharmaceutical Co., Ltd.'s market cap?
Kobayashi Pharmaceutical Co., Ltd.'s market capitalization is JPY 541.41B.
What is Kobayashi Pharmaceutical Co., Ltd.'s P/E ratio?
Kobayashi Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 333.2.
Does Kobayashi Pharmaceutical Co., Ltd. pay a dividend?
Kobayashi Pharmaceutical Co., Ltd. has a dividend yield of 1.5%.
What does Kobayashi Pharmaceutical Co., Ltd. do?
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally.